{"id":8,"date":"2025-11-05T17:03:17","date_gmt":"2025-11-05T17:03:17","guid":{"rendered":"https:\/\/kyriazoglou.gr\/?page_id=8"},"modified":"2026-01-10T04:44:03","modified_gmt":"2026-01-10T02:44:03","slug":"erevnitiko-kliniko-ergo","status":"publish","type":"page","link":"https:\/\/kyriazoglou.gr\/en\/erevnitiko-kliniko-ergo\/","title":{"rendered":"\u0395\u03c1\u03b5\u03c5\u03bd\u03b7\u03c4\u03b9\u03ba\u03cc \u03ba\u03b1\u03b9 \u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03cc \u0388\u03c1\u03b3\u03bf"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

\u0395\u03c1\u03b5\u03c5\u03bd\u03b7\u03c4\u03b9\u03ba\u03cc & \u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03cc \u0388\u03c1\u03b3\u03bf<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

BIOGRAPHICAL SKETCH<\/strong><\/p>

NAME:<\/p><\/td>

Anastasios Kyriazoglou, MD, PhD<\/p><\/td><\/tr>

eRA COMMONS USER NAME (credential, e.g., agency login):<\/p><\/td>

AKyriazoglou<\/p><\/td><\/tr>

POSITION TITLE:<\/p><\/td>

Assistant Professor of Medical Oncology, National and Kapodistrian University of Athens (Attikon University Hospital)<\/p><\/td><\/tr><\/tbody><\/table>

\u00a0<\/p>

EDUCATION\/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, include postdoctoral training and residency training if applicable. Add\/delete rows as necessary.)<\/p>

INSTITUTION AND LOCATION<\/p><\/td>

DEGREE (if applicable)<\/p><\/td>

Completion Date (MM\/YYYY)<\/p><\/td>

FIELD OF STUDY<\/p><\/td><\/tr>

University of Athens, School of Biology<\/p><\/td>

BSc<\/p><\/td>

06\/2004<\/p><\/td>

Biology<\/p><\/td><\/tr>

University of Athens, Medical School<\/p><\/td>

MD<\/p><\/td>

06\/2010<\/p><\/td>

Medicine<\/p><\/td><\/tr>

University of Ioannina, Medical School<\/p><\/td>

PhD<\/p><\/td>

12\/2010<\/p><\/td>

Molecular Oncology \/ Mesenchymal Tumors<\/p><\/td><\/tr>

Harvard Medical School \/ Brigham and Women\u2019s Hospital<\/p><\/td>

Postdoctoral Research<\/p><\/td>

09\/2016<\/p><\/td>

Molecular Pathology of Sarcomas<\/p><\/td><\/tr>

KU Leuven University Hospitals<\/p><\/td>

Residency \/ Research Fellowship<\/p><\/td>

11\/2019<\/p><\/td>

Medical Oncology \/ Sarcomas<\/p><\/td><\/tr><\/tbody><\/table>

\u00a0<\/p>

\u00a0<\/p>

A. Personal Statement<\/h2>

I am an Assistant Professor of Medical Oncology at the National and Kapodistrian University of Athens (Attikon University Hospital), specializing in sarcomas. My research integrates biomarker discovery and early-phase clinical development, focusing on antibody\u2013drug conjugates, radiomics, liquid biopsy, and digital pathology. I have led original research demonstrating NECTIN-4 expression in osteosarcoma and Ewing sarcoma, forming the foundation of this CDA proposal. My broader contributions include leadership in clinical trials, translational biomarker studies, and systematic reviews of novel therapeutics in sarcoma. Through strong mentorship and international collaborations (EORTC STBSG, Harvard, KU Leuven), I aim to establish Greece as a hub for innovative sarcoma research and early-phase clinical trials.

ORCID ID: 0000-0003-3222-4060
Google Scholar: https:\/\/scholar.google.com\/citations?user=f7nN4fMAAAAJ&hl=el<\/p>

B. Positions, Scientific Appointments, and Honors<\/h2>